Cite
HARVARD Citation
Banerjee, S. et al. (2020). Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK – A16037). Therapeutic advances in medical oncology. p. . [Online].